PMID- 18510572 OWN - NLM STAT- MEDLINE DCOM- 20090220 LR - 20211203 IS - 1365-2567 (Electronic) IS - 0019-2805 (Print) IS - 0019-2805 (Linking) VI - 125 IP - 4 DP - 2008 Dec TI - Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells. PG - 469-79 LID - 10.1111/j.1365-2567.2008.02860.x [doi] AB - Dendritic cells (DCs) play a key role in the type and course of an immune response. The manipulation of human DCs to produce therapeutic agents by transduction with viral vectors is a growing area of research. We present an investigation into the effects of adenoviral vector infection on human DCs and other cell types, and on their subsequent ability to induce T-cell proliferation. We show that infection with replication-deficient adenovirus results in impaired proliferation of T cells in a mixed lymphocyte reaction (MLR). We show this to be an active suppression rather than a defect in the DCs as T cells also fail to proliferate in response to phytohaemagglutinin in the presence of adenoviral vector-infected DCs. This suppression is not attributable to phenotypic changes, death or inability of the DCs to produce cytokines on stimulation. By separation of DCs from T cells, and addition of conditioned supernatants, we show that suppression is mediated by a soluble factor. Blocking of interleukin (IL)-10 but not transforming growth factor (TGF)-beta could overcome the suppressive effect in some donors, and the source of the suppressive IL-10 was lymphocytes exposed to conditioned supernatant. Together our data suggest that infection of DCs by adenoviral vectors leads to suppression of the resulting immune response. FAU - Newton, Katy R AU - Newton KR AD - Rheumatology Unit, Institute of Child Health, UCL, London, UK. k.newton@ich.ucl.ac.uk FAU - Sala-Soriano, Emma AU - Sala-Soriano E FAU - Varsani, Hemlata AU - Varsani H FAU - Stephenson, John R AU - Stephenson JR FAU - Goldblatt, David AU - Goldblatt D FAU - Wedderburn, Lucy R AU - Wedderburn LR LA - eng GR - Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080528 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Antibodies, Blocking) RN - 0 (Culture Media, Conditioned) RN - 0 (Cytokines) RN - 0 (Transforming Growth Factor beta) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Adenoviridae/genetics MH - Adenoviridae Infections/*immunology MH - Antibodies, Blocking/pharmacology MH - Cells, Cultured MH - Clonal Anergy MH - Culture Media, Conditioned MH - Cytokines/*immunology MH - Dendritic Cells/*immunology/*virology MH - Flow Cytometry MH - Genetic Vectors/administration & dosage MH - Humans MH - Immune Tolerance MH - Immunosuppression Therapy MH - Interleukin-10/immunology MH - Lymphocyte Culture Test, Mixed MH - T-Lymphocytes/*immunology MH - Transduction, Genetic/methods MH - Transforming Growth Factor beta/immunology PMC - PMC2612560 EDAT- 2008/05/31 09:00 MHDA- 2009/02/21 09:00 PMCR- 2009/12/01 CRDT- 2008/05/31 09:00 PHST- 2008/05/31 09:00 [pubmed] PHST- 2009/02/21 09:00 [medline] PHST- 2008/05/31 09:00 [entrez] PHST- 2009/12/01 00:00 [pmc-release] AID - IMM2860 [pii] AID - 10.1111/j.1365-2567.2008.02860.x [doi] PST - ppublish SO - Immunology. 2008 Dec;125(4):469-79. doi: 10.1111/j.1365-2567.2008.02860.x. Epub 2008 May 28.